Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

Market Cap	2.25B +0.6%
Revenue (ttm)	749.72M -12.6%
Net Income	9.11M -82.6%
EPS	0.04 -83.7%
Shares Out	235.30M
PE Ratio	247.03
Forward PE	n/a
Dividend	0.03 (0.31%)
Ex-Dividend Date	n/a

Volume	4,226,866
Average Volume	19,816,915
Open	9.64
Previous Close	9.56
Day's Range	9.45 - 9.64
52-Week Range	8.30 - 15.19
Beta	0.16
RSI	41.62
Earnings Date	Mar 31, 2026

About SHE:002873

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines in China. The company offers products in various dosage forms, including hard capsules, mixtures, granules, gels, tablets, syrups, wine preparation, dews preparations, and two Chinese medicine preparation production lines. Its products are used for the treatment of gynecological and urinary diseases, as well as oral, breast and thyroid, anti-cold, heat-clearing, blood-tonifying, cardiovascular disease, and antitu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,682
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002873

Financial Performance

In 2025, SHE:002873's revenue was 749.72 million, a decrease of -12.57% compared to the previous year's 857.55 million. Earnings were 9.11 million, a decrease of -82.59%.